ICOA
ANIP icon

Investment Centers of America’s ANI Pharmaceuticals ANIP Stock Holding History

Investment Centers of America’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-26,192
Closed -$240K – 357
2014
Q1 		$240K Buy
26,192
+14,601
+126% +$387K 0.05% 311
2013
Q4 		$105K Sell
11,591
-14,601
-56% -$189K 0.05% 243
2013
Q3 		$240K Buy
+26,192
New +$189K 0.05% 314

Other funds holding ANIP

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Investment Centers of America's ANIP Position: Q2 2014 in Review

Investment Centers of America sold out of ANI Pharmaceuticals (ANIP) in Q2 2014, closing a stake of 26,192 shares — an estimated $240K sold.

Investment Centers of America first reported a position in ANIP in Q3 2013 and held it in 3 quarters. The position peaked at $240K in Q1 2014. 81 funds tracked by Wall St. Rank hold ANIP as of Q2 2014.

  • Investment Centers of America reported no remaining ANI Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Investment Centers of America sold 26,192 ANI Pharmaceuticals shares in Q2 2014, an estimated $240K.
  • Investment Centers of America first reported a position in ANI Pharmaceuticals in Q3 2013 and held it in 3 quarters.
  • Investment Centers of America's ANI Pharmaceuticals position peaked at $240K in Q1 2014.
  • 81 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2014.

Based on Investment Centers of America's 13F filing for Q2 2014, filed 5 Aug 2014.